Don’t give vitamin D supplements to people who already have enough
Original: eternity4719 · source details
Original author: eternity4719 · Chinese source: · English adaptation: parveen0029. Translation and grade notes ↗
Bibliographic titles are retained in their original language.
Source author's views and grades; not individually verified by this site.
Cost and benefit at a glance
- Check the cost Cost ↓
- Roughly 0.2 to 0.5 yuan per day, or 100 to 200 yuan per year. That’s not much money, but the real cost is the false sense of security it gives — the belief that…
- Then the source benefit Benefit ↓
- The VITAL trial followed 25,871 participants who took 2,000 IU of vitamin D daily for a median 5.3 years: no statistically significant differences emerged across total invasive can…
In plain terms
For people who already have adequate vitamin D, taking supplements for 5 years yields identical rates of cancer, cardiovascular disease, and death as not taking them. Adults who rarely go outside and get no sunlight may take 400 IU daily, not exceeding 2,000 IU daily. Taking high doses actually accelerates volumetric bone loss and increases falls. Mere fatigue cannot be equated with vitamin D deficiency; if fatigued for weeks without clear reason, see a doctor.
This guide's cartoon · show illustration
Enlarge illustrationOriginal illustration with Chinese lettering; the English dialogue is below. Humour is a reading aid, not evidence.
English dialogue
- Everybody loves it!
- I'd like to read the original.
Cost: what it takes
Roughly 0.2 to 0.5 yuan per day, or 100 to 200 yuan per year. That’s not much money, but the real cost is the false sense of security it gives — the belief that you’ve already taken preventive steps.
Benefit: what the source reports
The VITAL trial followed 25,871 participants who took 2,000 IU of vitamin D daily for a median 5.3 years: no statistically significant differences emerged across total invasive cancer (HR 0.96, 95% CI 0.88–1.06), major cardiovascular events (HR 0.97, 95% CI 0.85–1.12), all-cause mortality (HR 0.99, 95% CI 0.87–1.12), or depression incidence (HR 0.97, 95% CI 0.87–1.09). In the Australian D-Health trial of 21,315 adults aged 60 and older receiving 60,000 IU monthly for 5 years, all-cause mortality showed no significant difference (HR 1.04, 95% CI 0.93–1.18). Regarding megadoses, the VITAL fracture substudy (25,842 participants) found 2,000 IU/day did not lower total fractures (HR 0.98) or hip fractures (HR 1.01). The Calgary 3-year bone mineral density trial (400 vs 4,000 vs 10,000 IU daily) demonstrated that higher doses led to greater volumetric bone loss. In a Swiss randomized trial of women aged >=70 comparing 100 IU vs 24,000 IU vs 60,000 IU monthly, the high-dose arms experienced significantly more falls (HR 1.77) despite achieving target serum 25(OH)D levels. An Australian trial testing an annual bolus of 500,000 IU in older women observed a 15% increase in falls and 26% increase in fractures.
Conditions, limits and disagreements
These trials specifically excluded people with proven severe clinical vitamin D deficiency, so findings apply to average individuals already getting sufficient intake. For individuals who rarely get sunlight exposure, national dietary guidelines recommend 400 IU daily, with a tolerable upper intake level of 2,000 IU daily for adults. Severe deficiency requires formal medical workup. Megadosing produces paradoxically poorer bone mineral outcomes and higher fall risks. Primary beneficiaries are yourself and your family.
Original references
Original bibliographic titles and links are preserved; some titles are in Chinese.
Manson JE et al. (2019). Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. NEJM. https://doi.org/10.1056/NEJMoa1809944;Neale RE et al. (2022). The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality. Lancet Diabetes Endocrinol. https://doi.org/10.1016/S2213-8587(21)00345-4;NHS. Vitamin D. https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-d/;NHS. Tiredness and fatigue. https://www.nhs.uk/symptoms/tiredness-and-fatigue/;国家卫生健康委员会. WS/T 578.4—2018 中国居民膳食营养素参考摄入量 第4部分:脂溶性维生素,表1. https://www.nhc.gov.cn/wjw/yingyang/201805/3dcd74635d8e40bcb5d834d3b2f66964/files/1739783549670_23371.pdf;LeBoff MS et al. (2022). Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults. NEJM. https://doi.org/10.1056/NEJMoa2202106;Burt LA et al. (2019). Effect of High-Dose Vitamin D Supplementation on Volumetric Bone Density and Bone Strength: A Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2019.11889;Bischoff-Ferrari HA et al. (2016). Monthly High-Dose Vitamin D Treatment for the Prevention of Functional Decline: A Randomized Clinical Trial. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2015.7148;Sanders KM et al. (2010). Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA. https://doi.org/10.1001/jama.2010.594;Munns CF et al. (2016). Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2015-2175;Mondal K et al. (2014). A Randomized controlled trial on safety and efficacy of single intramuscular versus staggered oral dose of 600 000IU Vitamin D in treatment of nutritional rickets. J Trop Pediatr. https://doi.org/10.1093/tropej/fmt105;Okereke OI et al. (2020). Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. JAMA. https://doi.org/10.1001/jama.2020.10224;Mikola T et al. (2023). The effect of vitamin D supplementation on depressive symptoms in adults: A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. https://doi.org/10.1080/10408398.2022.2096560;Ghaemi S et al. (2024). The effect of vitamin D supplementation on depression: a systematic review and dose-response meta-analysis of randomized controlled trials. Psychol Med. https://doi.org/10.1017/s0033291724001697
Medical, legal, financial and policy conditions vary by person, place and time. Policy material primarily concerns mainland China; check the cited document and current local requirements.